CIK 0001231457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
GENELUX Corp
Sign in to watch- Ticker
- GNLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 805-267-9889
- Business address
- 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $155,693
- in 6 filings
Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Cappello Joseph Chief Technical Officer | Sale | −668 | $2.04 | $1K | 317,812 |
| 2026-11-03 | Zindrick Thomas President and CEO | Sale | −3,089 | $2.05 | $6K | 1,223,338 |
| 2026-11-03 | Yu Yong Chief Scientific Officer | Sale | −668 | $2.01 | $1K | 258,020 |
| 2026-08-31 | Cappello Joseph Chief Technical Officer | Sale | −10,257 | $2.74 | $28K | 318,480 |
| 2026-08-31 | Zindrick Thomas President and CEO | Sale | −34,463 | $2.67 | $92K | 1,226,427 |
| 2026-08-31 | Yu Yong Chief Scientific Officer | Sale | −9,683 | $2.75 | $27K | 258,688 |
| 2026-08-04 | Yu Yong Chief Scientific Officer | Sale | −653 | $2.94 | $2K | 268,371 |
| 2026-08-04 | Cappello Joseph Chief Technical Officer | Sale | −653 | $2.95 | $2K | 328,737 |
| 2026-08-04 | Zindrick Thomas President and CEO | Sale | −3,023 | $2.95 | $9K | 1,260,890 |
| 2026-07-01 | Smither John W Director | Sale | −12,000 | $2.91 | $35K | 91,403 |
| 2026-06-16 | Pulisic Matthew Chief Financial Officer | Grant or award | +278,906 | 278,906 | ||
| 2026-06-16 | Groen Eric General Counsel | Grant or award | +233,957 | 233,957 | ||
| 2026-06-16 | Cappello Joseph Chief Technical Officer | Grant or award | +174,841 | 329,390 | ||
| 2026-06-16 | Tyree James L Director | Grant or award | +28,409 | 96,483 | ||
| 2026-06-16 | Tyree James L Director | Grant or award · Stock Option (Right to Buy) | +31,566 | 31,566 | ||
| 2026-06-16 | Zindrick Thomas President and CEO | Grant or award | +730,601 | 1,263,913 | ||
| 2026-06-16 | Thomas John Director | Grant or award | +28,409 | 501,193 | ||
| 2026-06-16 | Thomas John Director | Grant or award · Stock Option (Right to Buy) | +31,566 | 31,566 | ||
| 2026-06-16 | Mirabelli Mary Director | Grant or award | +28,409 | 102,693 | ||
| 2026-06-16 | Mirabelli Mary Director | Grant or award · Stock Option (Right to Buy) | +31,566 | 31,566 |
Page 1 of 9 · 170 trades